Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Sponsor: University of Chicago
Summary
The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions for participants. A PTC is a clinical that will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading this study will look for variations (differences) in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications. Individuals in this study will participate for roughly 9 months.
Official title: Evaluating the Effectiveness of a Personalized Therapeutics Clinic (PTC) Intervention on Drug-Drug Interactions (DDIs) and Drug-Gene Interactions (DGIs)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1300
Start Date
2022-11-30
Completion Date
2027-11-01
Last Updated
2026-03-04
Healthy Volunteers
No
Interventions
Drug-Drug Interaction Profile
A profile based on genetic testing that shows information about how the participant's medications they are taking interact with each other.
Drug-Gene Interaction Profile
A profile based on genetic testing that shows information about how the participant's genes interact with/respond to certain medications they are taking.
Standard of Care
The standard treatment and prescribing for the participant's specific type of cancer.
Locations (1)
University of Chicago Medicine
Chicago, Illinois, United States